Bulletin
Investor Alert

Centene Corp.

NYS: CNC

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 15, 2021, 7:51 p.m.

CNC
/zigman2/quotes/208900023/composite

$

64.00

Change

+0.01 +0.02%

Volume

Volume 70,870

Quotes are delayed by 20 min

/zigman2/quotes/208900023/composite

Previous close

$ 65.03

$ 63.99

Change

-1.04 -1.60%

Day low

Day high

$63.51

$64.83

Open

52 week low

52 week high

$43.96

$74.70

Open

Jeffrey A. Schwaneke

Presently, Jeffrey A. Schwaneke holds the position of Chief Financial Officer, Treasurer & Executive VP of Centene Corp. He is also on the board of Health Net LLC.

In his past career he was Segment Controller at SPX Corp. and Chief Accounting Officer, VP & Controller at Novelis, Inc.

He received an undergraduate degree from the University of Missouri.

Transactions

Date Shares Transaction Value
12/15/2020 90,000   Award at $59.73 per share. 5,375,700
12/15/2020 24,778   Derivative/Non-derivative trans. at $59.73 per share. 1,479,990
12/15/2020 19,368   Award at $49.85 per share. 965,494
12/12/2020 3,581   Derivative/Non-derivative trans. at $60.71 per share. 217,403
12/11/2020 5,967   Derivative/Non-derivative trans. at $61.31 per share. 365,837
12/10/2020 5,967   Derivative/Non-derivative trans. at $63.45 per share. 378,607
04/09/2020 7,500   Disposition at $68 per share. 510,000
02/12/2020 1,000   Gift at $0 per share. 0
02/04/2020 33,957   Derivative/Non-derivative trans. at $62.88 per share. 2,135,217
02/04/2020 27,840   Award at $28.13 per share. 783,139
12/13/2019 4,774   Derivative/Non-derivative trans. at $58.52 per share. 279,375
12/12/2019 3,580   Derivative/Non-derivative trans. at $58.64 per share. 209,932
12/11/2019 5,967   Derivative/Non-derivative trans. at $59.62 per share. 355,753
12/10/2019 100,000   Award at $59.17 per share. 5,917,000
02/05/2019 26,718   Derivative/Non-derivative trans. at $64.99 per share. 1,736,403
02/05/2019 19,600   Award at $28.4 per share. 556,640
01/15/2019 4,000   Disposition at $125 per share. 500,000
12/15/2018 3,017   Derivative/Non-derivative trans. at $127.53 per share. 384,759
12/13/2018 2,414   Derivative/Non-derivative trans. at $134.29 per share. 324,177
12/12/2018 1,811   Derivative/Non-derivative trans. at $132.83 per share. 240,556
12/11/2018 50,000   Award at $132.46 per share. 6,623,000
08/14/2018 150   Gift at $0 per share. 0
12/20/2017 400   Gift at $0 per share. 0
12/15/2017 3,197   Derivative/Non-derivative trans. at $99.02 per share. 316,567
12/13/2017 2,558   Derivative/Non-derivative trans. at $100.86 per share. 258,000
12/12/2017 30,000   Award at $99.7 per share. 2,991,000
12/09/2017 2,398   Derivative/Non-derivative trans. at $101.34 per share. 243,014
04/26/2017 150   Gift at $0 per share. 0
03/13/2017 2,000   Disposition at $68.52 per share. 137,040
02/27/2017 150   Gift at $0 per share. 0
01/11/2017 300   Gift at $0 per share. 0
12/15/2016 3,197   Derivative/Non-derivative trans. at $56.14 per share. 179,480
12/13/2016 40,000   Award at $56.26 per share. 2,250,400
12/10/2016 2,398   Derivative/Non-derivative trans. at $56.8 per share. 136,207
12/09/2016 2,398   Derivative/Non-derivative trans. at $56.94 per share. 136,543
03/24/2016 300   Gift at $0 per share. 0
02/09/2016 896   Derivative/Non-derivative trans. at $53.72 per share. 48,134

Officers and Executives

Mr. Michael F. Neidorff
Chairman, President & Chief Executive Officer
Ms. Brandy Burkhalter
Chief Operating Officer & Executive Vice President
Mr. Jeffrey A. Schwaneke
Chief Financial Officer, Treasurer & Executive VP
Dr. Ken Yamaguchi
Chief Medical Officer & Executive Vice President
Mr. Mark J. Brooks
Chief Information Officer & Executive VP
Dr. Mary V. Mason
Chief Medial Officer & Senior Vice President
Ms. Kathleen Hodson
Vice President-Staff Business Operations
Mr. David P. Thomas
Executive Vice President-Markets
Mr. Kenneth A. Burdick
Executive Vice President-Products & Markets
Mr. Andrew Lynn Asher
Executive Vice President-Envolve Specialty
Dr. Robert C. Packman
Senior Vice President-Medical Affairs
Ms. Holly Benson
Executive Vice President
Mr. Jesse N. Hunter
Chief Strategy Office, EVP-Mergers & Acquisition
Mr. Kevin J. Counihan
Senior Vice President-Products
Mr. Anand Shukla
SVP-Commercial Solutions
Mr. Arvan See Wing Chan
Regional Vice President & Corporate Operations
Mr. Brent Davis Layton
Chief Development Officer & Executive VP
Mr. Claudio Abreu
Executive Vice President
Mr. Matthew Snyder
SVP-Internal Audit, Compliance & Risk Management
Mr. Steven J. Sell
CEO & Plan President-CA Market
Mr. Patrick J. Frawley
Senior Vice President-Social Responsibility
Ms. Lori J. Robinson
Director
Mr. William L. Trubeck
Director
Mr. H. James Dallas
Director
Mr. Christopher R. Isaak
Chief Accounting Officer, Senior VP & Controller
Ms. Jennifer Gilligan
Senior Vice President-Investor Relations
Ms. Shannon Bagley
Executive Vice President-Human Resources
Mr. H. Robert Sanders
Executive Vice President-Human Resources
Mr. Christopher Koster
Secretary, Senior Vice President & General Counsel
Mr. Jonathan L. Dinesman
Executive Vice President-Government Relations
Mr. David L. Steward
Independent Director
Mr. Robert K. Ditmore
Independent Director
Dr. Tommy George Thompson
Independent Director
Mr. Orlando Lozano Ayala
Independent Director
Mr. Richard A. Gephardt
Independent Director
Mr. John R. Roberts
Independent Director
Mr. Frederick H. Eppinger
Independent Director
Ms. Jessica L. Blume
Independent Director
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.